PDL Biopharma
PDLI
#8100
Rank
NZ$0.49 B
Marketcap
NZ$4.34
Share price
-8.52%
Change (1 day)
N/A
Change (1 year)

Earnings for PDL Biopharma (PDLI)

Earnings in 2020 (TTM): -NZ$0.21 Billion

According to PDL Biopharma 's latest financial reports the company's current earnings are NZ$80.61 Million. In 2019 the company made an earning of -NZ$0.11 Billion a decrease over its 2018 earnings that were of -NZ$76.87 Million.

Earnings history for PDL Biopharma from 2001 to 2020

Annual earnings

Year Earnings Change
2020 (TTM)-NZ$0.21 Billion89.16%
2019-NZ$0.11 Billion42.43%
2018-NZ$76.87 Million-121.38%
2017NZ$0.35 B60.41%
2016NZ$0.22 B-77.09%
2015NZ$0.97 B3.09%
2014NZ$0.94 B26.65%
2013NZ$0.74 B19.82%
2012NZ$0.62 B3.68%
2011NZ$0.60 B77.17%
2010NZ$0.34 B-35.29%
2009NZ$0.52 B23.45%
2008NZ$0.42 B-1751.42%
2007-NZ$25.82 Million-88.56%
2006-NZ$0.23 Billion93.73%
2005-NZ$0.12 Billion13.63%
2004-NZ$0.11 Billion32.12%
2003-NZ$77.56 Million87.44%
2002-NZ$41.38 Million-302.45%
2001NZ$20.43 M

Earnings for similar companies or competitors

Company Earnings Earnings differencediff. Country
Eli Lilly
LLY
NZ$45.18 B-19,659.20%๐Ÿ‡บ๐Ÿ‡ธ USA
Amgen
AMGN
NZ$15.76 B-6,923.00%๐Ÿ‡บ๐Ÿ‡ธ USA
Sangamo Therapeutics
SGMO
-NZ$0.2 Billion-17.13%๐Ÿ‡บ๐Ÿ‡ธ USA
Compugen
CGEN
-NZ$48.41 Million-79.05%๐Ÿ‡ฎ๐Ÿ‡ฑ Israel
Nektar Therapeutics
NKTR
-NZ$0.28 Billion 18.19%๐Ÿ‡บ๐Ÿ‡ธ USA